1. Home
  2. CYCC vs AQB Comparison

CYCC vs AQB Comparison

Compare CYCC & AQB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYCC
  • AQB
  • Stock Information
  • Founded
  • CYCC 1992
  • AQB 1991
  • Country
  • CYCC United States
  • AQB United States
  • Employees
  • CYCC N/A
  • AQB N/A
  • Industry
  • CYCC Biotechnology: Pharmaceutical Preparations
  • AQB
  • Sector
  • CYCC Health Care
  • AQB
  • Exchange
  • CYCC Nasdaq
  • AQB Nasdaq
  • Market Cap
  • CYCC 3.6M
  • AQB 2.9M
  • IPO Year
  • CYCC N/A
  • AQB N/A
  • Fundamental
  • Price
  • CYCC $0.34
  • AQB $0.72
  • Analyst Decision
  • CYCC Strong Buy
  • AQB Hold
  • Analyst Count
  • CYCC 1
  • AQB 2
  • Target Price
  • CYCC $11.00
  • AQB N/A
  • AVG Volume (30 Days)
  • CYCC 404.4K
  • AQB 65.3K
  • Earning Date
  • CYCC 03-18-2025
  • AQB 03-31-2025
  • Dividend Yield
  • CYCC N/A
  • AQB N/A
  • EPS Growth
  • CYCC N/A
  • AQB N/A
  • EPS
  • CYCC N/A
  • AQB N/A
  • Revenue
  • CYCC $74,000.00
  • AQB $1,258,512.00
  • Revenue This Year
  • CYCC N/A
  • AQB N/A
  • Revenue Next Year
  • CYCC $88.68
  • AQB $43.65
  • P/E Ratio
  • CYCC N/A
  • AQB N/A
  • Revenue Growth
  • CYCC N/A
  • AQB N/A
  • 52 Week Low
  • CYCC $0.30
  • AQB $0.47
  • 52 Week High
  • CYCC $4.00
  • AQB $2.59
  • Technical
  • Relative Strength Index (RSI)
  • CYCC 46.57
  • AQB 43.04
  • Support Level
  • CYCC $0.32
  • AQB $0.71
  • Resistance Level
  • CYCC $0.38
  • AQB $0.77
  • Average True Range (ATR)
  • CYCC 0.02
  • AQB 0.04
  • MACD
  • CYCC 0.00
  • AQB -0.00
  • Stochastic Oscillator
  • CYCC 50.00
  • AQB 21.76

About CYCC Cyclacel Pharmaceuticals Inc.

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.

About AQB AquaBounty Technologies Inc.

AquaBounty Technologies Inc is engaged in the field of land-based aquaculture and the use of technology to improve the productivity and sustainability. The company's objective is to ensure the availability of high-quality seafood to meet consumer demand while addressing critical production constraints in the popular farmed species.

Share on Social Networks: